Key Insights
- Significant control over PharmaResources (Shanghai) by private companies implies that the general public has more power to influence management and governance-related decisions
- 55% of the business is held by the top 5 shareholders
- Insider ownership in PharmaResources (Shanghai) is 15%
To get a sense of who is truly in control of PharmaResources (Shanghai) Co., Ltd. (SZSE:301230), it is important to understand the ownership structure of the business. With 44% stake, private companies possess the maximum shares in the company. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).
Clearly, private companies benefitted the most after the company’s market cap rose by CN¥300m last week.
Let’s take a closer look to see what the different types of shareholders can tell us about PharmaResources (Shanghai).
